ID: ALA3642847

Max Phase: Preclinical

Molecular Formula: C17H29N3O2

Molecular Weight: 307.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)CCCC(n2cnc(CC(CCCN)C(=O)O)c2)C1

Standard InChI:  InChI=1S/C17H29N3O2/c1-17(2)7-3-6-15(10-17)20-11-14(19-12-20)9-13(16(21)22)5-4-8-18/h11-13,15H,3-10,18H2,1-2H3,(H,21,22)

Standard InChI Key:  ILWZFIDDSWMJSL-UHFFFAOYSA-N

Associated Targets(Human)

Carboxypeptidase B2 isoform A 351 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.44Molecular Weight (Monoisotopic): 307.2260AlogP: 3.01#Rotatable Bonds: 7
Polar Surface Area: 81.14Molecular Species: ZWITTERIONHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.91CX Basic pKa: 10.21CX LogP: 0.04CX LogD: 0.03
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.81Np Likeness Score: 0.61

References

1.  (2013)  Cycloalkyl-substituted imidazole derivative, 

Source

Source(1):